MODULATION OF HEMODYNAMIC-EFFECTS WITH A CONVERTING ENZYME-INHIBITOR - ACUTE HEMODYNAMIC DOSE-RESPONSE RELATIONSHIP OF A NEW ANGIOTENSIN CONVERTING ENZYME-INHIBITOR, LISINOPRIL, WITH OBSERVATIONS ON LONG-TERM CLINICAL, FUNCTIONAL, AND BIOCHEMICAL RESPONSESM

被引：35
|
作者：
URETSKY, BF
SHAVER, JA
LIANG, CS
AMIN, D
SHAH, PK
LEVINE, TB
WALINSKY, P
LEJEMTEL, T
LINNEMEIER, T
RUSH, JE
LANGENDORFER, A
SNAPINN, S
机构：
来源：
AMERICAN HEART JOURNAL | 1988年 / 116卷 / 02期
关键词：
D O I：
10.1016/0002-8703(88)90621-7
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：480 / 488
页数：9
相关论文
共 50 条
  • [21] HEMODYNAMIC-EFFECTS OF THE CONVERTING ENZYME-INHIBITOR TEPROTIDE IN NORMAL-RENIN AND HIGH-RENIN HYPERTENSION
    NIARCHOS, AP
    PICKERING, TG
    WALLACE, JM
    CASE, DB
    LARAGH, JH
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (05) : 592 - 601
  • [22] SEVERE ANGIOEDEMA AFTER LONG-TERM USE OF AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR
    CHIN, HL
    BUCHAN, DA
    ANNALS OF INTERNAL MEDICINE, 1990, 112 (04) : 312 - 313
  • [23] ACUTE EFFECTS OF MK421, A NEW ANGIOTENSIN CONVERTING ENZYME-INHIBITOR, IN MAN
    KASAI, Y
    ABE, K
    YASUJIMA, M
    TAJIMA, J
    SEINO, M
    CHIBA, S
    SATO, K
    GOTO, T
    OMATA, K
    TANNO, M
    YOSHINAGA, K
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 141 (04): : 417 - 422
  • [24] LONG-TERM TREATMENT OF CHRONIC CARDIAC-FAILURE BY AN ANGIOTENSIN CONVERTING ENZYME-INHIBITOR
    KOMAJDA, M
    EUGENE, M
    EVANS, J
    LAURENCEAU, JL
    HUBERMAN, JB
    THOMAS, D
    DROBINSKI, G
    LEPRINCE, JL
    GANTY, J
    WAJMAN, A
    GUEDJ, D
    GROSGOGEAT, Y
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1983, 76 (01): : 29 - 36
  • [25] ENALAPRIL - A NEW ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR IN CHRONIC HEART-FAILURE - ACUTE AND CHRONIC HEMODYNAMIC EVALUATIONS
    DICARLO, L
    CHATTERJEE, K
    PARMLEY, WW
    SWEDBERG, K
    ATHERTON, B
    CURRAN, D
    CUCCI, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1983, 2 (05) : 865 - 871
  • [26] ORAL ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR IN LONG-TERM TREATMENT OF HYPERTENSIVE PATIENTS
    BRUNNER, HR
    GAVRAS, H
    WAEBER, B
    KERSHAW, GR
    TURINI, GA
    VUKOVICH, RA
    MCKINSTRY, DN
    GAVRAS, I
    ANNALS OF INTERNAL MEDICINE, 1979, 90 (01) : 19 - 23
  • [27] COMPARATIVE HEMODYNAMIC-EFFECTS OF MK-422, A CONVERTING ENZYME-INHIBITOR, AND A RENIN INHIBITOR IN DOGS WITH ACUTE LEFT-VENTRICULAR FAILURE
    SWEET, CS
    LUDDEN, CT
    FREDERICK, CM
    BUSH, LR
    RIBEIRO, LGT
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1984, 6 (06) : 1067 - 1075
  • [28] PROMPT HEMODYNAMIC IMPROVEMENT IN HEART-FAILURE WITH AN INTRAVENOUS ANGIOTENSIN CONVERTING ENZYME-INHIBITOR, ENALAPRILAT
    WALINSKY, P
    POWERS, E
    LEJEMTEL, TH
    MASKIN, C
    FRANKL, WS
    BREST, AN
    JEFFERIES, L
    WHALEN, J
    JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 25 (06): : 464 - 464
  • [29] HEMODYNAMIC AND PHARMACOLOGICAL EFFECTS OF THE CONVERTING ENZYME-INHIBITOR CGS-14824A IN NORMAL VOLUNTEERS
    SCHALLER, MD
    NUSSBERGER, J
    WAEBER, B
    BUSSIEN, JP
    TURINI, GA
    BRUNNER, H
    BRUNNER, HR
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 28 (03) : 267 - 272
  • [30] ACUTE, SUBCHRONIC AND CHRONIC TOXICITY OF THE NEW ANGIOTENSIN CONVERTING ENZYME-INHIBITOR RAMIPRIL
    DONAUBAUER, HH
    MAYER, D
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1988, 38-1 (01): : 14 - 20
12345